nifedipine has been researched along with Gingival Hyperplasia in 145 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Gingival Hyperplasia: Non-inflammatory enlargement of the gingivae produced by factors other than local irritation. It is characteristically due to an increase in the number of cells. (From Jablonski's Dictionary of Dentistry, 1992, p400)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with nifedipine-induced gingival hyperplasia (GH) often require continued calcium channel blocker therapy." | 9.08 | Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine. ( Bednarczyk, EM; Bissada, NF; Carlson, M; Sheehan, H; Westbrook, P, 1997) |
| "Thirteen psoriatic patients with hypertension during the course of cyclosporin A therapy were treated for 25 months with a calcium channel blocker, sustained-release nifedipine, to study the clinical antihypertensive effects and adverse events during treatment with both drugs." | 9.08 | Long-term efficacy and adverse event of nifedipine sustained-release tablets for cyclosporin A-induced hypertension in patients with psoriasis. ( Furue, M; Koga, T; Nakayama, J, 1998) |
| "Nifedipine increases the frequency and severity of gingival hyperplasia associated with CyA therapy in renal transplant recipients and this effect appears to be independent of whole-blood CyA levels." | 9.07 | Cyclosporin, nifedipine and gingival hyperplasia: a randomized controlled study. ( Donnelly, PK; Edwards, CM; Morgan, JD; Swarbrick, MJ, 1994) |
| "A comprehensive review of the literature and analysis of the clinical history, mechanisms, pathogenesis, histology, and management of nifedipine-induced gingival hyperplasia is reported." | 8.79 | Nifedipine-induced gingival hyperplasia. A comprehensive review and analysis. ( Eckler, M; Gornitsky, M; Harel-Raviv, M; Lalani, K; Raviv, E, 1995) |
| "Nifedipine-induced gingival hyperplasia is a newly reported but relatively unknown side effect." | 8.77 | Nifedipine-induced gingival hyperplasia: case reports and literature review. ( Gotsman, M; Nyska, A; Nyska, M; Sela, M; Zlotogorski, A, 1989) |
| " Among the calcium channel blockers, nifedipine has been shown to be most frequently associated with drug-induced gingival hyperplasia." | 8.12 | Amlodipine Induced Gum Hypertrophy: A Rare Case Report. ( Bohra, GK; Chhabra, V; Kumar, D; Midha, N; Reddy, SC, 2022) |
| "This first case report of gingival hyperplasia induced by nifedipine in pregnancy could be used as a reference for clinicians in the management of this adverse effect during the pregnancy." | 7.85 | Nifedipine Induced Gingival Hyperplasia in Pregnancy: A Case Report. ( Brochet, MS; Harry, M; Morin, F, 2017) |
| "The use of calcium channel blockers, especially nifedipine, causes gingival hyperplasia which leads to the destruction of the deeper periodontal tissues." | 7.74 | [Histometric analysis of gingival hyperplasia in Wistar rats during nifedipine administration]. ( Brkić, Z, 2007) |
| "The results of our present study indicate that the synergistic overexpression of c-Myc and bcl-2 oncoprotein may be related to the pathogenesis of gingival hyperplasia induced by nifedipine and phenytoin, especially to the morphogenesis of hyperplastic epithelia." | 7.70 | Immunolocalizaiton of c-Myc and bcl-2 proto-oncogene products in gingival hyperplasia induced by nifedipine and phenytoin. ( Mori, S; Saito, K; Sakamoto, S; Tanda, N, 2000) |
| "Although it has been thought that drug-induced gingival hyperplasia is not related to tumorigenesis, recent case reports have shown that squamous cell carcinomas may arise in gingival hyperplasia induced by cyclosporin and phenytoin." | 7.70 | Expression of p53 protein and Ki-67 antigen in gingival hyperplasia induced by nifedipine and phenytoin. ( Mori, S; Saito, K; Sakamoto, S; Tanda, N, 1999) |
| "This study investigated the prevalence of gingival hyperplasia in subjects who were undergoing treatment with a calcium channel blocker, nifedipine, in dentate and edentulous subjects." | 7.69 | Prevalence of nifedipine-induced gingival hyperplasia. ( Edson, RG; Lee, KK; Nery, EB; Pruthi, VK; Watson, J, 1995) |
| " Nifedipine is often used to control hypertension in kidney graft recipients." | 7.69 | Nifedipine aggravates cyclosporine A-induced gingival hyperplasia. ( Albers, N; Beier, C; Bohnhorst, B; Bökenkamp, A; Brodehl, J; Offner, G, 1994) |
| "Gingival hyperplasia caused by the use of nifedipine has been extensively reported." | 7.69 | Clinical assessment of gingival hyperplasia in patients treated with nifedipine. ( Bullon, P; Lacalle, JR; Machuca, G; Martinez-Sahuquillo, A; Rios, JV; Rojas, J, 1994) |
| "Treatment with either cyclosporin A or nifedipine may induce gingival hyperplasia." | 7.69 | Gingival hyperplasia: interaction between cyclosporin A and nifedipine? A case report. ( Babich, S; Jackson, C, 1997) |
| "Two cases of gingival hyperplasia associated with long-term administration of nifedipine, a drug that dilates coronary arteries, are reported." | 7.68 | Nifedipine-induced gingival hyperplasia: a clinical and in vitro study. ( Hamasaki, A; Ishida, H; Kasahara, S; Kido, J; Nagata, T; Nishikawa, S; Tada, H; Wakano, Y, 1991) |
| "We describe 4 cases of gingival hyperplasia induced by nifedipine, together with clinical and histological findings." | 7.68 | Gingival hyperplasia induced by nifedipine. ( Akimoto, Y; Fujii, A; Kaneko, K; Kawana, T; Nakano, Y; Nakao, S; Omata, H; Shibutani, J; Tanaka, S; Teshigawara, H, 1991) |
| "Gingival hyperplasia is an adverse reaction of nifedipine therapy." | 7.68 | Nifedipine-induced gingival hyperplasia. ( Barak, S; Ben Yehuda, A; Katz, J; Rotstein, I, 1992) |
| "This article has summarized observations and results of controlled laboratory and clinical studies of drug-induced gingival hyperplasia associated with phenytoin, cyclosporine, and nifedipine use." | 7.67 | Drug-induced gingival hyperplasia: phenytoin, cyclosporine, and nifedipine. ( Butler, RT; Kaldahl, WB; Kalkwarf, KL, 1987) |
| "Nifedipine-induced gingival hyperplasia was first reported in 1984." | 7.67 | Nifedipine-induced gingival hyperplasia. ( Yusof, WZ, 1989) |
| "In a 32-year-old patient a relationship was suggested between the development of gingival hyperplasia and the vasodilating drug nifedipine (Adalat)." | 7.67 | Gingival hyperplasia induced by nifedipine, an arterial vasodilating drug. ( Hes, J; Tuinzing, DB; van der Wall, EE, 1985) |
| "A case of gingival hyperplasia associated with the administration of nifedipine is reported." | 7.67 | Gingival hyperplasia associated with nifedipine therapy. Report of a case. ( Freedman, PD; Lederman, D; Lumerman, H; Reuben, S, 1984) |
| "We observed marked gingival hyperplasia, similar clinically and histologically to the hyperplasia caused by 5:5 sodium diphenylhydantoin (Dilantin) during the last 18 months in five patients treated by nifedipine." | 7.67 | Gingival hyperplasia caused by nifedipine--a preliminary report. ( Behar, S; Engelberg, IS; Kishon, Y; Ramon, Y, 1984) |
| "Two cases of gingival hyperplasia associated with the administration of nifedipine are presented in this paper." | 7.67 | [Gingival hyperplasia induced by nifedipine. Report of two cases]. ( Andronikaki-Faldami, A; Nikolatou, O; Nikolopoulou-Papaconstantinou, A; Psaroulis, K, 1989) |
| "We describe a case of gingival hyperplasia in a 36-year-old renal transplantation recipient treated with nifedipine for severe arterial hypertension." | 7.67 | Gingival hyperplasia by nifedipine. Report of a case. ( Bencini, PL; Crosti, C; Menni, S; Montagnino, G; Piccinno, R; Sala, F; Tarantino, A, 1985) |
| "In a 66-year-old patient a relationship between the development of gingival hyperplasia and nifedipine treatment was suggested." | 7.67 | [Gingival hyperplasia caused by nifedipine]. ( Flaminio, R; Pivotti, F; Scardi, S, 1986) |
| "Gingival hyperplasia induced by nifedipine (Procardia), a calcium channel-blocking agent used as an anti-anginal drug, was studied." | 7.67 | Nifedipine-induced gingival hyperplasia. A histochemical and ultrastructural study. ( Howell, LP; Lucas, RM; Wall, BA, 1985) |
| "The prevalence of the nifedipine-induced gingival hyperplasia is ranging from 0." | 6.19 | [Clinical experience with the treatment of gingival hyperplasia induced by calcium channel blocking agents]. ( Benedek, E; Gera, I; Keglevich, T, 1999) |
| "Twenty-day nifedipine treatment induced gingival hyperplasia accompanied with reduced salivary flow rate and concentrations of total protein, epidermal growth factor (EGF) and calcium in comparison with controls." | 5.33 | On the relation of nitric oxide to nifedipine-induced gingival hyperplasia and impaired submandibular glands function in rats in vivo. ( Abdollahi, M; Khorasani, R; Minaiee, B; Rezaie, A; Rezaie, S, 2005) |
| "Nifedipine is a new agent belonging to the calcium antagonist group of drugs, applied clinically to circulatory disorders, such as essential hypertension, renal hypertension and angina cordis and has been rapid in gaining popularity in Japan." | 5.28 | [A case of gingival hyperplasia induced by nifedipine]. ( Kakami, K; Kaneko, M; Katayama, H; Kinoshita, Y; Suzuki, N; Takai, Y, 1990) |
| "Patients with nifedipine-induced gingival hyperplasia (GH) often require continued calcium channel blocker therapy." | 5.08 | Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine. ( Bednarczyk, EM; Bissada, NF; Carlson, M; Sheehan, H; Westbrook, P, 1997) |
| "Thirteen psoriatic patients with hypertension during the course of cyclosporin A therapy were treated for 25 months with a calcium channel blocker, sustained-release nifedipine, to study the clinical antihypertensive effects and adverse events during treatment with both drugs." | 5.08 | Long-term efficacy and adverse event of nifedipine sustained-release tablets for cyclosporin A-induced hypertension in patients with psoriasis. ( Furue, M; Koga, T; Nakayama, J, 1998) |
| "Nifedipine increases the frequency and severity of gingival hyperplasia associated with CyA therapy in renal transplant recipients and this effect appears to be independent of whole-blood CyA levels." | 5.07 | Cyclosporin, nifedipine and gingival hyperplasia: a randomized controlled study. ( Donnelly, PK; Edwards, CM; Morgan, JD; Swarbrick, MJ, 1994) |
| " Among the calcium channel blockers, nifedipine has been shown to be most frequently associated with drug-induced gingival hyperplasia." | 4.12 | Amlodipine Induced Gum Hypertrophy: A Rare Case Report. ( Bohra, GK; Chhabra, V; Kumar, D; Midha, N; Reddy, SC, 2022) |
| "Severe gingival hyperplasia (GH) is one of the most frequent side-effects associated with the prescription of Cyclosporine-A (CsA)." | 3.71 | Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients. ( Baboolal, K; Newcombe, RG; Subramanian, N; Thomas, DW, 2001) |
| "Although it has been thought that drug-induced gingival hyperplasia is not related to tumorigenesis, recent case reports have shown that squamous cell carcinomas may arise in gingival hyperplasia induced by cyclosporin and phenytoin." | 3.70 | Expression of p53 protein and Ki-67 antigen in gingival hyperplasia induced by nifedipine and phenytoin. ( Mori, S; Saito, K; Sakamoto, S; Tanda, N, 1999) |
| "A case report is presented, which describes a kidney-transplant recipient medicated simultaneously with both cyclosporin A and nifedipine and who developed an extreme form of gingival hyperplasia." | 3.70 | [Drug-induced gingival hyperplasia]. ( Ferrari, P; Nohl, F, 1998) |
| " Although KGF has been implicated in a number of hyperplastic pathologies, it has not previously been investigated in gingival hyperplasia (GH), an adverse side-effect of three pharmacologically different types of drugs, including the anti-hypertensive drug nifedipine (NIF)." | 3.70 | Keratinocyte growth factor is upregulated by the hyperplasia-inducing drug nifedipine. ( Das, SJ; Olsen, I, 2000) |
| "Treatment with either cyclosporin A or nifedipine may induce gingival hyperplasia." | 3.69 | Gingival hyperplasia: interaction between cyclosporin A and nifedipine? A case report. ( Babich, S; Jackson, C, 1997) |
| "Gingival hyperplasia caused by the use of nifedipine has been extensively reported." | 3.69 | Clinical assessment of gingival hyperplasia in patients treated with nifedipine. ( Bullon, P; Lacalle, JR; Machuca, G; Martinez-Sahuquillo, A; Rios, JV; Rojas, J, 1994) |
| "Human gingival fibroblasts from six patients who developed gingival hyperplasia as a result of nifedipine medication and five who did not were studied for the effects of calcium-channel blockers (nifedipine, diltiazem, verapamil and nicardipine) on cell proliferation, DNA synthesis and collagen synthesis." | 3.69 | Effect of calcium-channel blockers on cell proliferation, DNA synthesis and collagen synthesis of cultured gingival fibroblasts derived from human nifedipine responders and non-responders. ( Akimoto, Y; Fujii, A; Matsumoto, H; Nakao, S; Teshigawara, H, 1994) |
| " Nifedipine is often used to control hypertension in kidney graft recipients." | 3.69 | Nifedipine aggravates cyclosporine A-induced gingival hyperplasia. ( Albers, N; Beier, C; Bohnhorst, B; Bökenkamp, A; Brodehl, J; Offner, G, 1994) |
| " The relative amounts of extracellular matrix macromolecules observed in 12 cases of gingival hyperplasia associated with the use of cyclosporin, hydantoin or nifedipine were compared with those obtained in a control group on the basis of histological and immunohistochemical investigations." | 3.69 | Changes in extracellular matrix macromolecules in human gingiva after treatment with drugs inducing gingival overgrowth. ( Bonnaure-Mallet, M; Godeau, GJ; Tricot-Doleux, S, 1995) |
| "This study investigated the prevalence of gingival hyperplasia in subjects who were undergoing treatment with a calcium channel blocker, nifedipine, in dentate and edentulous subjects." | 3.69 | Prevalence of nifedipine-induced gingival hyperplasia. ( Edson, RG; Lee, KK; Nery, EB; Pruthi, VK; Watson, J, 1995) |
| "A case of severe gingival overgrowth associated with combined drug therapy of cyclosporin A and nifedipine is reported." | 3.69 | Combined treatment approach to gingival overgrowth due to drug therapy. ( Darbar, UR; Hopper, C; Newman, HN; Speight, PM, 1996) |
| " Gingival overgrowth associated with cyclosporin (immunosuppressant agent) and nifedipine (calcium channel blocker) is well documented." | 3.69 | Periodontal management of gingival overgrowth in the heart transplant patient: a case report. ( Khocht, A; Schneider, LC, 1997) |
| "Gingival hyperplasia is an adverse reaction of nifedipine therapy." | 3.68 | Nifedipine-induced gingival hyperplasia. ( Barak, S; Ben Yehuda, A; Katz, J; Rotstein, I, 1992) |
| "We describe a case of gingival hyperplasia in a 36-year-old renal transplantation recipient treated with nifedipine for severe arterial hypertension." | 3.67 | Gingival hyperplasia by nifedipine. Report of a case. ( Bencini, PL; Crosti, C; Menni, S; Montagnino, G; Piccinno, R; Sala, F; Tarantino, A, 1985) |
| "We observed marked gingival hyperplasia, similar clinically and histologically to the hyperplasia caused by 5:5 sodium diphenylhydantoin (Dilantin) during the last 18 months in five patients treated by nifedipine." | 3.67 | Gingival hyperplasia caused by nifedipine--a preliminary report. ( Behar, S; Engelberg, IS; Kishon, Y; Ramon, Y, 1984) |
| "Gingival hyperplasia induced by nifedipine (Procardia), a calcium channel-blocking agent used as an anti-anginal drug, was studied." | 3.67 | Nifedipine-induced gingival hyperplasia. A histochemical and ultrastructural study. ( Howell, LP; Lucas, RM; Wall, BA, 1985) |
| "Nifedipine-induced gingival hyperplasia was first reported in 1984." | 3.67 | Nifedipine-induced gingival hyperplasia. ( Yusof, WZ, 1989) |
| " Animals in each group daily received NIF in dimethyl sulfoxide by gastric feeding at a dosage of 0 (control), 30, or 50 mg/kg body weight for 9 weeks." | 2.40 | Nifedipine-induced gingival overgrowth in rats: brief review and experimental study. ( Fu, E; Hsiao, CT; Hsieh, YD; Nieh, S; Shen, EC; Wikesjö, UM, 1998) |
| " In the majority of those patients for whom dosage reduction, or drug discontinuation or substitution is not possible, and for whom prophylactic measures have failed, surgical excision of gingival tissue remains the only treatment of choice." | 2.39 | Gingival enlargement induced by drugs. ( Berini, L; Brunet, L; Farré, M; Mendieta, C; Miranda, J, 1996) |
| "Twenty-day nifedipine treatment induced gingival hyperplasia accompanied with reduced salivary flow rate and concentrations of total protein, epidermal growth factor (EGF) and calcium in comparison with controls." | 1.33 | On the relation of nitric oxide to nifedipine-induced gingival hyperplasia and impaired submandibular glands function in rats in vivo. ( Abdollahi, M; Khorasani, R; Minaiee, B; Rezaie, A; Rezaie, S, 2005) |
| "Nifedipine-untreated and dimethylsulfoxide (DMSO)-treated animals served as control groups." | 1.32 | Effect of nifedipine on the expression of bcl-2 protein in rat gingiva. ( Handajani, J; Haniastuti, T; Santoso, AL; Sosroseno, W; Utoro, T, 2003) |
| "Gingival hyperplasia was not associated with any of the CsA-PK studied parameters." | 1.31 | Impact of cyclosporin A pharmacokinetics on the presence of side effects in pediatric renal transplantation. ( Arai Furusawa, E; Cavalcante, JS; David-Neto, E; Ianhez, LE; Lemos, FBC; Romano, P; Schwartzman, BS; Yagyu, EM, 2000) |
| "Treatment with nifedipine in rats led to the inducement of gingival hyperplasia and increase in the numbers of p53-positive gingival epithelial cells by a dose and frequency dependent mechanism, suggesting that p53 protein may play a crucial role in the regulation of nifedipine-induced gingival hyperplasia." | 1.31 | Effect of nifedipine on the expression of p53 protein in rat gingiva. ( Agustina, D; Agustiono, P; Haniastuti, T; Santoso, AS; Sosroseno, W, 2002) |
| "The incidence of gingival hyperplasia has been reported as 10%-20% in patients treated with calcium antagonists in the general population." | 1.30 | Incidence of gingival hyperplasia caused by calcium antagonists in continuous ambulatory peritoneal dialysis patients. ( Nakamoto, H; Okada, H; Shouda, J; Sugahara, S; Suzuki, H, 1999) |
| "Gingival hyperplasia was only weakly related to plaque and calculus but was unrelated to CsA dose (mg/kg/day), duration of CsA therapy (months), CsA blood or saliva levels (ng/ml), or the concurrent administration of a Nif or Dz." | 1.29 | Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists. ( Francis, DM; Fullinfaw, R; Higgins, TJ; King, GN; Walker, RG; Wiesenfeld, D, 1993) |
| "Six children had enamel hypoplasia, three in permanent incisors and three in primary incisors." | 1.29 | Oral findings in children with liver transplants. ( Gordon, G; Hosey, MT; Kelly, DA; Shaw, L, 1995) |
| "The mechanism of gingival overgrowth associated with long-term use of nifedipine and of other drugs that affect calcium homoeostasis, such as cyclosporin and phenytoin, is unknown." | 1.28 | Gingival sequestration of nifedipine in nifedipine-induced gingival overgrowth. ( Ellis, JS; Idle, JR; Monkman, SC; Seymour, RA, 1992) |
| " Gingival changes in the nifedipine patients were not related to drug dosage or plaque scores." | 1.28 | The incidence and severity of nifedipine-induced gingival overgrowth. ( Barclay, S; Idle, JR; Seymour, RA; Thomason, JM, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 37 (25.52) | 18.7374 |
| 1990's | 86 (59.31) | 18.2507 |
| 2000's | 17 (11.72) | 29.6817 |
| 2010's | 4 (2.76) | 24.3611 |
| 2020's | 1 (0.69) | 2.80 |
| Authors | Studies |
|---|---|
| Reddy, SC | 1 |
| Midha, N | 1 |
| Chhabra, V | 1 |
| Kumar, D | 1 |
| Bohra, GK | 1 |
| Asif, SM | 1 |
| Shaik, N | 1 |
| Barthunia, B | 1 |
| Kaleem, SM | 1 |
| Zakirulla, M | 1 |
| Kota, MZ | 1 |
| Baig, FAH | 1 |
| van Montfort, M | 1 |
| Huisman, L | 1 |
| Brochet, MS | 1 |
| Harry, M | 1 |
| Morin, F | 1 |
| Cohen, D | 1 |
| Bhattacharyya, I | 1 |
| Haniastuti, T | 2 |
| Santoso, AS | 1 |
| Agustiono, P | 1 |
| Agustina, D | 1 |
| Sosroseno, W | 2 |
| Shimizu, Y | 1 |
| Kataoka, M | 2 |
| Seto, H | 1 |
| Kido, J | 4 |
| Nagata, T | 6 |
| Handajani, J | 1 |
| Santoso, AL | 1 |
| Utoro, T | 1 |
| Rezaie, S | 1 |
| Rezaie, A | 1 |
| Minaiee, B | 1 |
| Khorasani, R | 1 |
| Abdollahi, M | 1 |
| Brkić, Z | 2 |
| Hosey, MT | 1 |
| Gordon, G | 1 |
| Kelly, DA | 1 |
| Shaw, L | 1 |
| Bahamondes, C | 1 |
| Godoy, J | 1 |
| van der Wall, EE | 2 |
| Tuinzing, DB | 2 |
| Hes, J | 2 |
| Lederman, D | 1 |
| Lumerman, H | 1 |
| Reuben, S | 1 |
| Freedman, PD | 1 |
| Ramon, Y | 1 |
| Behar, S | 1 |
| Kishon, Y | 1 |
| Engelberg, IS | 2 |
| Thomason, JM | 6 |
| Seymour, RA | 9 |
| Ellis, JS | 5 |
| Kelly, PJ | 1 |
| Parry, G | 1 |
| Dark, J | 1 |
| Idle, JR | 4 |
| González Romero, EA | 1 |
| López Sánchez, AF | 1 |
| Granados Menéndez, MI | 1 |
| Hernández Vallejo, G | 1 |
| Butler, TJ | 2 |
| Nery, EB | 1 |
| Edson, RG | 1 |
| Lee, KK | 1 |
| Pruthi, VK | 1 |
| Watson, J | 1 |
| Harel-Raviv, M | 1 |
| Eckler, M | 1 |
| Lalani, K | 1 |
| Raviv, E | 1 |
| Gornitsky, M | 1 |
| Ishida, H | 5 |
| Kondoh, T | 1 |
| Nishikawa, S | 4 |
| Nakagawa, T | 1 |
| Morisaki, I | 2 |
| Oka, T | 2 |
| Bonnaure-Mallet, M | 1 |
| Tricot-Doleux, S | 1 |
| Godeau, GJ | 1 |
| Ramsdale, DR | 1 |
| Morris, JL | 1 |
| Hardy, P | 1 |
| McKevitt, KM | 1 |
| Irwin, CR | 1 |
| Rees, TD | 1 |
| Levine, RA | 1 |
| Salerno, L | 1 |
| Pepe, S | 1 |
| Gullotti, D | 1 |
| Iacò, V | 1 |
| Rossmann, JA | 1 |
| Ingles, E | 1 |
| Brown, RS | 2 |
| Bökenkamp, A | 1 |
| Bohnhorst, B | 1 |
| Beier, C | 1 |
| Albers, N | 1 |
| Offner, G | 1 |
| Brodehl, J | 1 |
| Zebrowski, EJ | 1 |
| Pylypas, SP | 1 |
| Odlum, O | 1 |
| Johnson, RB | 1 |
| Mathis, DE | 1 |
| Scheetz, AP | 1 |
| Naylor, CD | 1 |
| Steele, RM | 1 |
| Schuna, AA | 1 |
| Schreiber, RT | 1 |
| Fujii, A | 2 |
| Matsumoto, H | 1 |
| Nakao, S | 2 |
| Teshigawara, H | 2 |
| Akimoto, Y | 2 |
| Bullon, P | 2 |
| Machuca, G | 2 |
| Martinez-Sahuquillo, A | 1 |
| Rios, JV | 1 |
| Rojas, J | 1 |
| Lacalle, JR | 1 |
| Rice, N | 1 |
| Romanos, GE | 3 |
| Schröter-Kermani, C | 2 |
| Hinz, N | 2 |
| Herrmann, D | 1 |
| Strub, JR | 2 |
| Bernimoulin, JP | 3 |
| King, GN | 1 |
| Fullinfaw, R | 1 |
| Higgins, TJ | 1 |
| Walker, RG | 1 |
| Francis, DM | 1 |
| Wiesenfeld, D | 1 |
| O'Valle, F | 1 |
| Mesa, F | 1 |
| Aneiros, J | 1 |
| Gómez-Morales, M | 1 |
| Lucena, MA | 1 |
| Ramírez, C | 1 |
| Revelles, F | 1 |
| Moreno, E | 1 |
| Navarro, N | 1 |
| Caballero, T | 1 |
| Silverstein, LH | 2 |
| Koch, JP | 2 |
| Shatz, PC | 1 |
| Lefkove, MD | 1 |
| Garnick, JJ | 1 |
| Singh, B | 1 |
| Steflik, DE | 1 |
| Hapak, L | 1 |
| Brunet, L | 1 |
| Miranda, J | 1 |
| Farré, M | 1 |
| Berini, L | 1 |
| Mendieta, C | 1 |
| Darbar, UR | 1 |
| Hopper, C | 1 |
| Speight, PM | 1 |
| Newman, HN | 1 |
| Lowry, LY | 1 |
| Welbury, RR | 1 |
| Waterhouse, PJ | 1 |
| Hamilton, JR | 1 |
| Saito, K | 3 |
| Mori, S | 3 |
| Iwakura, M | 1 |
| Sakamoto, S | 3 |
| Frieman, J | 1 |
| Jackson, C | 1 |
| Babich, S | 1 |
| Deen-Duggins, L | 1 |
| Fry, HR | 1 |
| Clay, JR | 1 |
| Turner, JR | 1 |
| Westbrook, P | 1 |
| Bednarczyk, EM | 1 |
| Carlson, M | 1 |
| Sheehan, H | 1 |
| Bissada, NF | 1 |
| Jorgensen, MG | 1 |
| Khocht, A | 1 |
| Schneider, LC | 1 |
| Ciantar, M | 1 |
| Santi, E | 1 |
| Bral, M | 1 |
| Shoieb, MA | 1 |
| Fathy, LM | 1 |
| Abu-el-Dahab, O | 1 |
| el-Sherbiny, MM | 1 |
| Botha, PJ | 1 |
| Fu, E | 1 |
| Nieh, S | 1 |
| Hsiao, CT | 1 |
| Hsieh, YD | 1 |
| Wikesjö, UM | 1 |
| Shen, EC | 1 |
| Pilloni, A | 1 |
| Camargo, PM | 1 |
| Carere, M | 1 |
| Carranza, FA | 1 |
| Varga, E | 1 |
| Mair, LH | 1 |
| Nohl, F | 1 |
| Ferrari, P | 1 |
| Payne, VM | 1 |
| Nakayama, J | 1 |
| Koga, T | 1 |
| Furue, M | 1 |
| Steele, JG | 1 |
| Robertson, P | 1 |
| Tanda, N | 2 |
| Keglevich, T | 1 |
| Benedek, E | 1 |
| Gera, I | 1 |
| Türkmen, A | 1 |
| Ak, G | 1 |
| Furuncuoglu, Y | 1 |
| Akar, U | 1 |
| Seyhun, Y | 1 |
| Türk, S | 1 |
| Carin, M | 1 |
| Sever, MS | 1 |
| David-Neto, E | 1 |
| Lemos, FBC | 1 |
| Arai Furusawa, E | 1 |
| Schwartzman, BS | 1 |
| Cavalcante, JS | 1 |
| Yagyu, EM | 1 |
| Romano, P | 1 |
| Ianhez, LE | 1 |
| Shouda, J | 1 |
| Nakamoto, H | 1 |
| Sugahara, S | 1 |
| Okada, H | 1 |
| Suzuki, H | 1 |
| Missouris, GG | 1 |
| Kalaitzidis, RG | 1 |
| Cappuccio, FP | 1 |
| MacGregor, GA | 1 |
| Das, SJ | 1 |
| Olsen, I | 1 |
| Morgan, JD | 1 |
| Swarbrick, MJ | 1 |
| Edwards, CM | 1 |
| Donnelly, PK | 1 |
| Houston, GD | 1 |
| Thomas, DW | 1 |
| Baboolal, K | 1 |
| Subramanian, N | 1 |
| Newcombe, RG | 1 |
| Armas, JR | 1 |
| Rojas, JL | 1 |
| Jiménez, G | 1 |
| Riley, CK | 1 |
| Terezhalmy, GT | 1 |
| James, JA | 1 |
| Linden, GJ | 1 |
| Monkman, SC | 1 |
| Bhatia, RS | 1 |
| Barclay, S | 1 |
| Sauget, P | 1 |
| Monteil, RA | 1 |
| Morand, P | 1 |
| Loubiere, R | 1 |
| Lapalus, P | 1 |
| Haudebourg, C | 1 |
| Royo, M | 1 |
| Arto, A | 1 |
| Tam, IM | 1 |
| Wandres, DL | 1 |
| Burkes, EJ | 1 |
| Jacoway, JR | 1 |
| Stevens, DT | 1 |
| Braddock, ME | 1 |
| Katz, J | 1 |
| Rotstein, I | 1 |
| Ben Yehuda, A | 1 |
| Barak, S | 3 |
| Beaver, WT | 1 |
| Bottomley, WK | 1 |
| Hancock, RH | 1 |
| Swan, RH | 1 |
| Tanaka, S | 1 |
| Omata, H | 1 |
| Shibutani, J | 1 |
| Nakano, Y | 1 |
| Kaneko, K | 1 |
| Kawana, T | 1 |
| Braun, T | 1 |
| Sponholz, F | 1 |
| Sponholz, H | 1 |
| MacCarthy, D | 1 |
| Claffey, N | 1 |
| García Bernal, G | 1 |
| Collado, A | 1 |
| Cerón, A | 1 |
| Goffin, M | 1 |
| Mohapatra, BN | 1 |
| Kar, BC | 1 |
| Das, P | 1 |
| Gupta, AK | 1 |
| Gupta, P | 1 |
| Tada, H | 1 |
| Hamasaki, A | 3 |
| Kasahara, S | 1 |
| Wakano, Y | 3 |
| Bosker, H | 1 |
| Jordan, RD | 1 |
| Sindet-Pedersen, S | 1 |
| Koole, R | 1 |
| Kleber, BM | 1 |
| Strahlendorf, F | 1 |
| Marcos Sánchez, F | 2 |
| Arranz Nieto, MJ | 1 |
| Celdrán Gil, J | 2 |
| Durán Pérez Navarro, A | 1 |
| Mellado Calvo, N | 1 |
| Durán, A | 1 |
| Sanz Cantalapiedra, R | 1 |
| Dalfó Baqué, A | 1 |
| Martín Arias, LH | 1 |
| Carvajal García-Pando, A | 1 |
| Tagawa, T | 1 |
| Nakamura, H | 1 |
| Murata, M | 1 |
| Zlotogorski, A | 2 |
| Nyska, A | 3 |
| Katayama, H | 1 |
| Kinoshita, Y | 1 |
| Kaneko, M | 1 |
| Suzuki, N | 1 |
| Kakami, K | 1 |
| Takai, Y | 1 |
| Doria, G | 1 |
| Cangemi, F | 1 |
| Gulizia, M | 1 |
| Lo Giudice, P | 1 |
| Circo, A | 1 |
| Bencini, PL | 1 |
| Crosti, C | 1 |
| Sala, F | 2 |
| Montagnino, G | 1 |
| Tarantino, A | 1 |
| Menni, S | 1 |
| Piccinno, R | 1 |
| Lundergan, WP | 1 |
| Andronikaki-Faldami, A | 1 |
| Nikolatou, O | 1 |
| Nikolopoulou-Papaconstantinou, A | 1 |
| Psaroulis, K | 1 |
| De Camargo, PM | 1 |
| Yusof, WZ | 2 |
| Matarasso, S | 1 |
| Vaia, E | 1 |
| Caputo, G | 1 |
| Riccitiello, F | 1 |
| Nyska, M | 2 |
| Sela, M | 2 |
| Gotsman, M | 1 |
| Ferrés, E | 1 |
| López Colomés, JL | 1 |
| Moreno, A | 1 |
| Villena, J | 1 |
| Veraldi, S | 2 |
| Piferi, M | 2 |
| Marini, D | 2 |
| Slavin, J | 1 |
| Taylor, J | 1 |
| Chicco, GN | 1 |
| Fletcher, P | 1 |
| Kaplan, I | 1 |
| Silvestri, E | 1 |
| Bencini, L | 1 |
| Puolijoki, H | 2 |
| Siitonen, L | 2 |
| Saha, H | 2 |
| Suojanen, I | 2 |
| Raman, PG | 1 |
| Mishra, VN | 1 |
| Singh, D | 1 |
| Waner, T | 1 |
| Pirak, M | 1 |
| Galiano, A | 1 |
| Tejerina Lobo, JM | 1 |
| Mencia Fernandez, C | 1 |
| Martos Molino, F | 1 |
| Simarro Martin-Ambrosio, E | 1 |
| Jones, CM | 1 |
| Chomette, G | 1 |
| Auriol, M | 1 |
| Szpirglas, H | 1 |
| Ragot, J | 1 |
| Thomas, D | 1 |
| Cabrol, C | 1 |
| Vaillant, JM | 1 |
| Butler, RT | 1 |
| Kalkwarf, KL | 1 |
| Kaldahl, WB | 1 |
| Glenert, U | 1 |
| Hansen, HJ | 1 |
| Pindborg, JJ | 1 |
| Lainson, PA | 1 |
| Hiss, J | 1 |
| Ciancio, SG | 1 |
| Pignanelli, M | 1 |
| Mattei, R | 1 |
| Ueno, A | 1 |
| Koda, N | 2 |
| Gómez-Fernández, P | 1 |
| Pérez, R | 1 |
| Gallego, P | 1 |
| Almaraz, M | 1 |
| Scardi, S | 1 |
| Pivotti, F | 1 |
| Flaminio, R | 1 |
| Lucas, RM | 1 |
| Howell, LP | 1 |
| Wall, BA | 1 |
| Masuda, T | 1 |
| Kagawa, K | 1 |
| Ebuchi, Y | 1 |
20 reviews available for nifedipine and Gingival Hyperplasia
| Article | Year |
|---|---|
Nifedipine-induced gingival hyperplasia. A comprehensive review and analysis.
Topics: Calcium; Female; Gingival Hyperplasia; Gingivoplasty; Humans; Middle Aged; Nifedipine | 1995 |
Systematic drugs as a risk factor for periodontal disease initiation and progression.
Topics: Calcium Channel Blockers; Cyclosporine; Female; Fibromatosis, Gingival; Gingival Hyperplasia; Gonada | 1995 |
Oral and dental problems in the organ transplant patient.
Topics: Anti-Bacterial Agents; Cyclosporine; Dental Care for Chronically Ill; Gingival Hyperplasia; Humans; | 1994 |
Pathogenesis of drug-induced gingival overgrowth. A review of studies in the rat model.
Topics: Age Factors; Animals; Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Dental Plaque; Diseas | 1996 |
Periodontal management of nifedipine-induced gingival overgrowth: a case report and review of the pertinent literature.
Topics: Calcium Channel Blockers; Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine; Periodontitis | 1994 |
Gingival enlargement induced by drugs.
Topics: Anticonvulsants; Calcium Channel Blockers; Cyclosporine; Gingival Hyperplasia; Humans; Immunosuppres | 1996 |
Nifedipine-associated gingival overgrowth: a survey of the literature and report of four cases.
Topics: Adult; Aged; Calcium Channel Blockers; Female; Gingival Hyperplasia; Humans; Male; Middle Aged; Nife | 1996 |
Nifedipine-induced gingival overgrowth: remission following non-surgical therapy.
Topics: Calcium Channel Blockers; Combined Modality Therapy; Dental Plaque; Denture, Partial, Removable; Gin | 1996 |
Drug-induced gingival hyperplasia and its management--a literature review.
Topics: Anticonvulsants; Calcium Channel Blockers; Clinical Protocols; Cyclosporine; Gingival Hyperplasia; H | 1997 |
Nifedipine-induced gingival overgrowth in rats: brief review and experimental study.
Topics: Analysis of Variance; Animals; Body Weight; Calcium Channel Blockers; Disease Models, Animal; Dose-R | 1998 |
[Clinical experience with the treatment of gingival hyperplasia induced by calcium channel blocking agents].
Topics: Calcium Channel Blockers; Gingival Hyperplasia; Gingivectomy; Humans; Nifedipine; Oral Hygiene | 1999 |
The patient with hypertension.
Topics: Anesthesia, Dental; Calcium Channel Blockers; Coronary Disease; Dental Care for Chronically Ill; Eme | 2001 |
[Gingival hyperplasia secondary to the use of calcium antagonists: analysis].
Topics: Adult; Aged; Aged, 80 and over; Diltiazem; Epithelium; Female; Fibroblasts; Gingiva; Gingival Hyperp | 1992 |
Calcium-channel blockers and gingival hyperplasia.
Topics: Aged; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Female; Gingival Hyperplasia; Hu | 1992 |
On the mechanism of drug-induced gingival hyperplasia.
Topics: Dental Plaque; Diltiazem; Epidermal Growth Factor; Fibroblasts; Folic Acid; Gingival Hyperplasia; Gl | 1991 |
[Gingival hyperplasia in a heart transplant patient treated with cyclosporin A and nifedipine].
Topics: Adolescent; Cyclosporins; Gingival Hyperplasia; Heart Transplantation; Humans; Male; Nifedipine | 1991 |
Calcium channel blockers and gingival overgrowth.
Topics: Calcium Channel Blockers; Cyclosporins; Diltiazem; Fibroblasts; Gingival Hyperplasia; Humans; Nifedi | 1991 |
Cyclosporin- and nifedipine-induced gingival enlargement: an overview.
Topics: Cyclosporins; Gingival Hyperplasia; Humans; Nifedipine | 1989 |
[Hyperthrophic-hyperplastic gingival diseases. Etiopathogenic, clinical assessment and diagnostic guide].
Topics: Anticonvulsants; Cyclosporins; Fibromatosis, Gingival; Gingival Hyperplasia; Gingival Hypertrophy; G | 1989 |
Nifedipine-induced gingival hyperplasia: case reports and literature review.
Topics: Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine | 1989 |
6 trials available for nifedipine and Gingival Hyperplasia
| Article | Year |
|---|---|
Calcium antagonist-induced gingival hyperplasia.
Topics: Adult; Aged; Calcium Channel Blockers; Cross-Sectional Studies; Diltiazem; Gingival Hyperplasia; Hum | 1994 |
Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine.
Topics: Adult; Aged; Antihypertensive Agents; Biopsy; Calcium Channel Blockers; Dental Plaque Index; Evaluat | 1997 |
Surgical treatment of cyclosporine A- and nifedipine-induced gingival enlargement: gingivectomy versus periodontal flap.
Topics: Adolescent; Adult; Calcium Channel Blockers; Child; Cyclosporine; Female; Gingival Hyperplasia; Ging | 1998 |
Long-term efficacy and adverse event of nifedipine sustained-release tablets for cyclosporin A-induced hypertension in patients with psoriasis.
Topics: Adult; Aged; Blood Pressure Determination; Calcium Channel Blockers; Cyclosporine; Delayed-Action Pr | 1998 |
[Clinical experience with the treatment of gingival hyperplasia induced by calcium channel blocking agents].
Topics: Calcium Channel Blockers; Gingival Hyperplasia; Gingivectomy; Humans; Nifedipine; Oral Hygiene | 1999 |
Cyclosporin, nifedipine and gingival hyperplasia: a randomized controlled study.
Topics: Calcium Channel Blockers; Cyclosporine; Drug Interactions; Gingival Hyperplasia; Gingivectomy; Human | 1994 |
120 other studies available for nifedipine and Gingival Hyperplasia
| Article | Year |
|---|---|
Amlodipine Induced Gum Hypertrophy: A Rare Case Report.
Topics: Aged; Amlodipine; Calcium Channel Blockers; Gingival Hyperplasia; Gingival Overgrowth; Humans; Hyper | 2022 |
Nifedipine induced gingival enlargement in an edentulous patient: a case report with one year follow up.
Topics: Aged; Calcium Channel Blockers; Gingiva; Gingival Hyperplasia; Gingivectomy; Humans; Hypertension; M | 2018 |
[A woman with gingival hyperplasia].
Topics: Aged; Calcium Channel Blockers; Female; Gingival Hyperplasia; Humans; Incidence; Nifedipine; Prevale | 2014 |
Nifedipine Induced Gingival Hyperplasia in Pregnancy: A Case Report.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Female; Gingival Hyperplasia; Humans; Nifedipine; | 2017 |
Case of the month: drug-induced hyperplasia.
Topics: Adult; Cyclosporine; Diagnosis, Differential; Female; Gingival Hyperplasia; Humans; Nifedipine; Phen | 2008 |
Oral pathology quiz # 75. Case number 4. Systemic medication.
Topics: Anticonvulsants; Cyclosporine; Diagnosis, Differential; Gingival Hyperplasia; Humans; Immunosuppress | 2012 |
Effect of nifedipine on the expression of p53 protein in rat gingiva.
Topics: Animals; Gingiva; Gingival Hyperplasia; Male; Nifedipine; Rats; Rats, Sprague-Dawley; Tumor Suppress | 2002 |
Nifedipine induces gingival epithelial hyperplasia in rats through inhibition of apoptosis.
Topics: Animals; Antimetabolites; Apoptosis; Bromodeoxyuridine; Calcium Channel Blockers; Cell Division; Cel | 2002 |
Effect of nifedipine on the expression of bcl-2 protein in rat gingiva.
Topics: Animals; Calcium Channel Blockers; Dose-Response Relationship, Drug; Epithelial Cells; Gingiva; Ging | 2003 |
On the relation of nitric oxide to nifedipine-induced gingival hyperplasia and impaired submandibular glands function in rats in vivo.
Topics: Animals; Arginine; Calcium; Calcium Channel Blockers; Epidermal Growth Factor; Gingival Hyperplasia; | 2005 |
[Histopathologic investigations of nifedipine-induced gingival hyperplasia in Wistar rats].
Topics: Animals; Calcium Channel Blockers; Gingiva; Gingival Hyperplasia; Male; Nifedipine; Periodontium; Ra | 2005 |
Oral findings in children with liver transplants.
Topics: Adolescent; Biliary Atresia; Child; Child, Preschool; Cyclosporine; Dental Enamel Hypoplasia; Gingiv | 1995 |
[Histometric analysis of gingival hyperplasia in Wistar rats during nifedipine administration].
Topics: Animals; Calcium Channel Blockers; Gingiva; Gingival Hyperplasia; Male; Nifedipine; Rats; Rats, Wist | 2007 |
[Cyclosporine-induced gingival hyperplasia: report of one case].
Topics: Biofilms; Calcium Channel Blockers; Cyclosporine; Gingiva; Gingival Hyperplasia; Humans; Immunosuppr | 2007 |
[Gingival hyperplasia: a possible side effect of nifedipine].
Topics: Adult; Female; Gingival Hyperplasia; Humans; Hypertension, Pulmonary; Nifedipine | 1984 |
Gingival hyperplasia associated with nifedipine therapy. Report of a case.
Topics: Female; Gingival Hyperplasia; Gingivectomy; Humans; Middle Aged; Nifedipine | 1984 |
Gingival hyperplasia caused by nifedipine--a preliminary report.
Topics: Aged; Coronary Artery Bypass; Female; Gingiva; Gingival Hyperplasia; Humans; Hypertension; Male; Mid | 1984 |
Iatrogenic gingival overgrowth in cardiac transplantation.
Topics: Adolescent; Adult; Age Factors; Calcium Channel Blockers; Cyclosporine; Drug Synergism; Female; Ging | 1995 |
[Drug-induced gingival hyperplasia].
Topics: Adult; Calcium Channel Blockers; Child; Cyclosporins; Gingival Hyperplasia; Humans; Hydantoins; Nife | 1995 |
Periodontal variables affecting nifedipine sequestration in gingival crevicular fluid.
Topics: Adult; Calcium Channel Blockers; Confounding Factors, Epidemiologic; Dental Plaque Index; Dose-Respo | 1995 |
Prevalence of nifedipine-induced gingival hyperplasia.
Topics: Age Factors; Biopsy; Calcium Channel Blockers; Collagen; Connective Tissue; Dentition; Epithelium; F | 1995 |
Factors influencing nifedipine-induced gingival overgrowth in rats.
Topics: Age Factors; Analysis of Variance; Animal Feed; Animals; Dose-Response Relationship, Drug; Female; G | 1995 |
Changes in extracellular matrix macromolecules in human gingiva after treatment with drugs inducing gingival overgrowth.
Topics: Collagen; Cyclosporine; Elastic Tissue; Elastin; Extracellular Matrix; Extracellular Matrix Proteins | 1995 |
Gingival hyperplasia with nifedipine.
Topics: Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine | 1995 |
Phenotypic differences in growth, matrix synthesis and response to nifedipine between fibroblasts derived from clinically healthy and overgrown gingival tissue.
Topics: Analysis of Variance; Collagen; Female; Fibroblasts; Gingival Hyperplasia; Humans; Male; Middle Aged | 1995 |
[Gingival hyperplasia induced by amlodipine].
Topics: Adult; Amlodipine; Calcium Channel Blockers; Gingival Hyperplasia; Humans; Hypertension; Male; Nifed | 1995 |
Multimodal treatment of drug-induced gingival hyperplasia in a kidney transplant patient.
Topics: Adult; Chlorhexidine; Cyclosporine; Dental Care for Chronically Ill; Dental Plaque; Drug Interaction | 1994 |
Nifedipine aggravates cyclosporine A-induced gingival hyperplasia.
Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Gingival Hyperplas | 1994 |
Comparative metabolism of 3H-glucosamine by fibroblast populations exposed to cyclosporine.
Topics: Adult; Cell Count; Cells, Cultured; Chronic Disease; Cyclosporine; Extracellular Matrix; Fibroblasts | 1994 |
Calcium channel antagonists and gingival hyperplasia.
Topics: Confounding Factors, Epidemiologic; Gingival Hyperplasia; Humans; Nifedipine | 1994 |
Calcium channel antagonists and gingival hyperplasia.
Topics: Gingival Hyperplasia; Humans; Nifedipine; Periodontal Diseases | 1994 |
Effect of calcium-channel blockers on cell proliferation, DNA synthesis and collagen synthesis of cultured gingival fibroblasts derived from human nifedipine responders and non-responders.
Topics: Adult; Aged; Calcium Channel Blockers; Cell Count; Cell Division; Cells, Cultured; Collagen; DNA; Fe | 1994 |
Clinical assessment of gingival hyperplasia in patients treated with nifedipine.
Topics: Dental Plaque Index; Dose-Response Relationship, Drug; Female; Gingival Hemorrhage; Gingival Hyperpl | 1994 |
The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth.
Topics: Adult; Cohort Studies; Cyclosporine; Dental Plaque Index; Drug Combinations; Female; Gingival Hemorr | 1993 |
Extracellular matrix analysis of nifedipine-induced gingival overgrowth: immunohistochemical distribution of different collagen types as well as the glycoprotein fibronectin.
Topics: Adult; Basement Membrane; Collagen; Extracellular Matrix; Female; Fibronectins; Fluorescent Antibody | 1993 |
Immunohistochemical distribution of extracellular matrix proteins as a diagnostic parameter in healthy and diseased gingiva.
Topics: Adult; Aged; Collagen; Cyclosporine; Extracellular Matrix Proteins; Female; Fibronectins; Fluorescen | 1993 |
Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists.
Topics: Adult; Cross-Sectional Studies; Cyclosporine; Dental Calculus; Dental Plaque Index; Diltiazem; Drug | 1993 |
Gingival overgrowth induced by nifedipine and cyclosporin A. Clinical and morphometric study with image analysis.
Topics: Adult; Calcium Channel Blockers; Case-Control Studies; Cyclosporine; Drug Synergism; Female; Follow- | 1995 |
Nifedipine-induced gingival hyperplasia.
Topics: Calcium Channel Blockers; Gingival Hyperplasia; Humans; Nifedipine | 1996 |
Nifedipine-induced gingival enlargement around dental implants: a clinical report.
Topics: Animals; Calcium Channel Blockers; Cats; Dental Care for Chronically Ill; Dental Implants; Female; G | 1995 |
Combined treatment approach to gingival overgrowth due to drug therapy.
Topics: Blood Loss, Surgical; Calcium Channel Blockers; Carbon Dioxide; Cyclosporine; Gingival Hemorrhage; G | 1996 |
Gingival overgrowth in paediatric cardiac transplant patients: a study of 19 patients aged between 2 and 16 years.
Topics: Adolescent; Calcium Channel Blockers; Child; Child, Preschool; Cyclosporine; Dental Care for Chronic | 1995 |
Immunohistochemical localization of transforming growth factor beta, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phenytoin.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Calcium Channel Blockers; Cell Count; Coloring Agents; Fem | 1996 |
Alternative protocol.
Topics: Calcium Channel Blockers; Chlorhexidine; Drug Administration Schedule; Gingival Hyperplasia; Humans; | 1996 |
Gingival hyperplasia: interaction between cyclosporin A and nifedipine? A case report.
Topics: Calcium Channel Blockers; Cyclosporine; Drug Synergism; Female; Gingival Hyperplasia; Gingival Pocke | 1997 |
Prevalence of amlodipine-related gingival hyperplasia.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Calcium Channel Blockers; Dental Plaque Index; Female; G | 1997 |
Periodontal management of gingival overgrowth in the heart transplant patient: a case report.
Topics: Calcium Channel Blockers; Candidiasis, Oral; Connective Tissue; Cyclosporine; Epithelium; Fibrosis; | 1997 |
Effect of treatment on cyclosporine- and nifedipine-induced gingival enlargement: clinical and histologic results.
Topics: Adult; Aged; Anti-Infective Agents, Local; Chlorhexidine; Combined Modality Therapy; Cyclosporine; D | 1998 |
A clinical and histological comparative study of the effect of nifedipine and phenytion on human gingiva.
Topics: Anticonvulsants; Biopsy; Calcium Channel Blockers; Gingiva; Gingival Hyperplasia; Humans; Nifedipine | 1993 |
Medication influencing the development of gingival overgrowth in renal transplant patients.
Topics: Cyclosporine; Gingiva; Gingival Hyperplasia; Gingivitis; Humans; Immunosuppressive Agents; Kidney Fa | 1998 |
[Drug-induced gingival hyperplasia].
Topics: Adult; Antihypertensive Agents; Calcium Channel Blockers; Cyclosporine; Drug Therapy, Combination; F | 1998 |
Re: Periodontal management of gingival overgrowth in the heart transplant patient: a case report (1997;68:1140-1146)
Topics: Adult; Azathioprine; Calcium Channel Blockers; Candidiasis, Oral; Chlorhexidine; Cyclosporine; Gingi | 1998 |
Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Analysis of Variance; Calcium Channel Blockers; Dental P | 1999 |
Gingival hyperplasia due to calcium antagonists.
Topics: Calcium Channel Blockers; Dihydropyridines; Diltiazem; Gingival Hyperplasia; Humans; Nifedipine; Ver | 1998 |
Expression of p53 protein and Ki-67 antigen in gingival hyperplasia induced by nifedipine and phenytoin.
Topics: Adolescent; Adult; Anticonvulsants; Biomarkers, Tumor; Calcium Channel Blockers; Carcinoma, Squamous | 1999 |
Relationship between gingival hyperplasia and class II histocompatibility antigens in renal transplant recipients.
Topics: Adult; Calcium Channel Blockers; Cyclosporine; Female; Gingival Hyperplasia; Histocompatibility Anti | 2000 |
Impact of cyclosporin A pharmacokinetics on the presence of side effects in pediatric renal transplantation.
Topics: Adolescent; Adult; Antihypertensive Agents; Child; Cyclosporine; Female; Gingival Hyperplasia; Hand; | 2000 |
Incidence of gingival hyperplasia caused by calcium antagonists in continuous ambulatory peritoneal dialysis patients.
Topics: Adult; Amlodipine; Calcium Channel Blockers; Cardiovascular Diseases; Felodipine; Female; Gingival H | 1999 |
Immunolocalizaiton of c-Myc and bcl-2 proto-oncogene products in gingival hyperplasia induced by nifedipine and phenytoin.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Calcium Channel Blockers; Epithelial Cells; Epithelium; Fe | 2000 |
Gingival hyperplasia caused by calcium channel blockers.
Topics: Calcium Channel Blockers; Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine | 2000 |
Keratinocyte growth factor is upregulated by the hyperplasia-inducing drug nifedipine.
Topics: Antihypertensive Agents; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Epitop | 2000 |
Oral pathology case of the quarter.
Topics: Angina Pectoris; Calcium Channel Blockers; Diagnosis, Differential; Gingival Hyperplasia; Gingivitis | 2001 |
Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients.
Topics: Adolescent; Adult; Aged; Azathioprine; Calcium Channel Blockers; Child; Child, Preschool; Creatinine | 2001 |
The gingival inflammatory infiltrate in cardiac patients treated with calcium antagonists.
Topics: Analysis of Variance; Calcium Channel Blockers; Case-Control Studies; Chi-Square Distribution; Dilti | 2001 |
Nifedipine-induced gingival hyperplasia.
Topics: Aged; Female; Gingival Hyperplasia; Humans; Nifedipine | 1992 |
Gingival sequestration of nifedipine in nifedipine-induced gingival overgrowth.
Topics: Gingiva; Gingival Hyperplasia; Humans; Male; Nifedipine | 1992 |
Nifedipine induced reversible gingival hyperplasia.
Topics: Female; Gingival Hyperplasia; Humans; Hypertension; India; Middle Aged; Nifedipine | 1992 |
Distribution of fibronectin in healthy, inflamed and drug-induced gingival hyperplasia.
Topics: Actin Cytoskeleton; Adult; Connective Tissue; Connective Tissue Cells; Cyclosporine; Dental Plaque; | 1992 |
The incidence and severity of nifedipine-induced gingival overgrowth.
Topics: Atenolol; Dental Plaque Index; Female; Gingival Hyperplasia; Gingival Pocket; Humans; Incidence; Mal | 1992 |
[Calcium antagonists and gingival hyperplasia].
Topics: Adult; Gingival Hyperplasia; Humans; Male; Nifedipine | 1992 |
Nifedipine-induced gingival hyperplasia.
Topics: Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine | 1992 |
Nifedipine-induced gingival hyperplasia.
Topics: Adult; Angina Pectoris; Female; Gingival Hemorrhage; Gingival Hyperplasia; Humans; Male; Middle Aged | 1992 |
Nifedipine-induced gingival overgrowth. Report of a case treated by controlling plaque.
Topics: Dental Calculus; Dental Plaque; Dental Scaling; Gingival Hyperplasia; Humans; Male; Middle Aged; Nif | 1992 |
Gingival hyperplasia induced by nifedipine.
Topics: Aged; Female; Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine | 1991 |
[Side effects of the immunsuppressive cyclosporin A in dentistry].
Topics: Adult; Cyclosporine; Female; Gingival Hyperplasia; Humans; Kidney Transplantation; Male; Middle Aged | 1991 |
Fibrous hyperplasia of the gingiva in organ transplant patients.
Topics: Adult; Cyclosporins; Dental Care for Disabled; Gingival Hyperplasia; Gingivectomy; Heart Transplanta | 1991 |
[Gingival hyperplasia as an adverse reaction to nifedipine].
Topics: Gingival Hyperplasia; Humans; Nifedipine | 1991 |
Nifedipine-induced gum hyperplasia.
Topics: Adult; Female; Gingival Hyperplasia; Humans; Hypertension; Nifedipine | 1991 |
Nifedipine-induced gingival hyperplasia.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Female; Gingival Hyperplasia; Humans; Hypertension; Male; | 1991 |
Nifedipine-induced gingival hyperplasia: a clinical and in vitro study.
Topics: Cell Division; Cells, Cultured; Collagen; Connective Tissue; Female; Fibroblasts; Gingival Hyperplas | 1991 |
The transmandibular implant: a 13-year survey of its use.
Topics: Adult; Aged; Aged, 80 and over; Dental Implantation, Endosseous; Female; Follow-Up Studies; Gingival | 1991 |
[Clinical aspects of gingival hyperplasia].
Topics: Cyclosporins; Gingival Hyperplasia; Humans; Hydantoins; Nifedipine | 1990 |
[Gingival hyperplasia induced by nifedipine].
Topics: Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine | 1990 |
[Gingival hyperplasia and nifedipine].
Topics: Female; Gingival Hyperplasia; Humans; Hypertension; Middle Aged; Nifedipine | 1990 |
[Gingival hyperplasia produced by nifedipine].
Topics: Delayed-Action Preparations; Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine; Time Facto | 1990 |
Marked gingival hyperplasia induced by nifedipine.
Topics: Female; Gingival Hyperplasia; Humans; Hypertension; Middle Aged; Nifedipine | 1990 |
A case of marked gingival hyperplasia induced by nifedipine.
Topics: Gingival Hyperplasia; Humans; Nifedipine | 1990 |
[A case of gingival hyperplasia induced by nifedipine].
Topics: Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine | 1990 |
[3 cases of gingival hyperplasia during nifedipine therapy].
Topics: Adult; Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine; Time Factors | 1990 |
Gingival hyperplasia by nifedipine. Report of a case.
Topics: Adult; Gingival Hyperplasia; Humans; Hypertension, Renal; Kidney Transplantation; Male; Nifedipine | 1985 |
Drug-induced gingival enlargements.
Topics: Adult; Cyclosporins; Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine; Phenytoin | 1989 |
[Gingival hyperplasia induced by nifedipine. Report of two cases].
Topics: Aged; Female; Gingival Hyperplasia; Humans; Male; Nifedipine | 1989 |
Nifedipine-induced gingival hyperplasia.
Topics: Coronary Disease; Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine | 1989 |
[Gingival hyperplasia associated with nifedipine].
Topics: Adult; Gingival Hyperplasia; Humans; Male; Nifedipine; Phenytoin | 1989 |
Gingival hyperplasia following nifedipine therapy.
Topics: Adult; Aged; Female; Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine | 1989 |
Cyclosporin, nifedipine, and gingival hyperplasia.
Topics: Cyclosporins; Female; Gingival Hyperplasia; Humans; Nifedipine; Postoperative Complications | 1987 |
[Calcium antagonists and gingival hyperplasia].
Topics: Collagen; Dental Scaling; Epidermolysis Bullosa; Gingival Hyperplasia; Humans; Male; Mastication; Mi | 1988 |
Nifedipine (Procardia) and gingival hyperplasia: a new diagnostic concern for practitioners.
Topics: Aged; Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine | 1986 |
The CO2 laser in the excision of gingival hyperplasia caused by nifedipine.
Topics: Adult; Carbon Dioxide; Gingival Hyperplasia; Humans; Laser Therapy; Male; Nifedipine | 1988 |
[Gingival hyperplasia due to diphenylhydantoin, cyclosporin A and nifedipine. A histopathological comparison].
Topics: Biopsy; Connective Tissue; Cyclosporins; Gingiva; Gingival Hyperplasia; Humans; Nifedipine; Phenytoi | 1988 |
[Nifedipine-induced gingival hyperplasia].
Topics: Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine | 1988 |
Nifedipine induced gingival hyperplasia.
Topics: Diabetes Mellitus, Type 2; Female; Gingival Hyperplasia; Humans; Middle Aged; Myocardial Infarction; | 1988 |
Gingival hyperplasia in dogs induced by oxodipine, a calcium channel blocking agent.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Calcium Channel Blockers; Dihydropyridines; Dog | 1988 |
Gingival hyperplasia caused by nifedipine.
Topics: Gingival Hemorrhage; Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine | 1988 |
Gingival hyperplasia: an intra-oral side effect of phenytoin, nifedipine and cyclosporine therapies.
Topics: Adult; Cyclosporins; Female; Gingival Hyperplasia; Humans; Nifedipine; Phenytoin | 1988 |
[Ifedipine induced gingival hyperplasia. Review and clinical cases].
Topics: Angina Pectoris; Female; Gingival Hyperplasia; Gingivectomy; Humans; Male; Middle Aged; Nifedipine | 1988 |
Gingival hyperplasia associated with nifedipine.
Topics: Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine | 1986 |
[Essential and iatrogenic gingival hyperplasia. Its morphology and significance].
Topics: Adolescent; Adult; Chronic Disease; Cyclosporins; Female; Gingiva; Gingival Hyperplasia; Gingivectom | 1986 |
Drug-induced gingival hyperplasia: phenytoin, cyclosporine, and nifedipine.
Topics: Adult; Child; Cyclosporins; Female; Gingival Hyperplasia; Humans; Male; Nifedipine; Phenytoin | 1987 |
[Gingiva hyperplasia caused by nifedipine therapy].
Topics: Gingival Hyperplasia; Humans; Male; Middle Aged; Nifedipine | 1986 |
Gingival overgrowth in a patient treated with nifedipine (Procardia).
Topics: Adult; Gingival Hyperplasia; Humans; Male; Nifedipine | 1986 |
Gingival hyperplasia caused by nifedipine. Histopathologic findings.
Topics: Adult; Aged; Epithelium; Female; Gingiva; Gingival Hyperplasia; Humans; Keratosis; Male; Middle Aged | 1987 |
Drugs in dentistry. Medications for gingival hyperplasia.
Topics: Cyclosporins; Gingival Hyperplasia; Humans; Nifedipine; Phenytoin | 1987 |
[Gingival hyperplasia from nifedipine].
Topics: Aged; Gingival Hyperplasia; Gingivectomy; Humans; Male; Middle Aged; Nifedipine | 1987 |
[Gingival hyperplasia induced by nifedipine. Effect of nifedipine and EGF on cell proliferation in human gingival fibroblasts].
Topics: Cell Division; DNA; Epidermal Growth Factor; Fibroblasts; Gingiva; Gingival Hyperplasia; Humans; Nif | 1986 |
[Nifedipine-induced gingival hyperplasia].
Topics: Adult; Gingival Hyperplasia; Humans; Male; Nifedipine | 1987 |
[Gingival hyperplasia caused by nifedipine].
Topics: Aged; Gingival Hyperplasia; Humans; Male; Nifedipine | 1986 |
Nifedipine-induced gingival hyperplasia. A histochemical and ultrastructural study.
Topics: Acid Phosphatase; Adult; Aged; Alcian Blue; Female; Fibroblasts; Gingiva; Gingival Hyperplasia; Huma | 1985 |
[Clinical and histopathological observations of the gingiva in heart patients treated with nifedipine--a report of 3 cases].
Topics: Gingiva; Gingival Hyperplasia; Heart Diseases; Humans; Male; Middle Aged; Nifedipine | 1985 |
Gingival hyperplasia induced by nifedipine, an arterial vasodilating drug.
Topics: Adult; Female; Gingiva; Gingival Hyperplasia; Humans; Nifedipine | 1985 |